Prospective study of oral anticoagulation control in 110 very elderly hospitalized patients and of risk factors for poor control;Difficultés pour équilibrer les antivitamines K chez des personnes très âgées hospitalisées : étude prospective chez 110 patients avec recherche de facteurs de risque de déséquilibre

Presse Medicale

Volumn 37, Issue 12, 2008, Pages 1723-1730

  Vogel, Thomas ^a   Coriol, Virginie ^a   Kaltenbach, Georges ^a   Kiesmann, Michèle ^a   Berthel, Marc ^a  

^a Ctr de Gerontologie des Hop Univ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUINDIONE;

AGED; ANTICOAGULATION; ARTICLE; BRAIN HEMATOMA; CLINICAL TRIAL; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; PHENINDIONE; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN K;

EID: 56649109804     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.04.005     Document Type: Article

References (23)

1. Ansell J., Hirsh J.U., Poller L., Bussey H., Jacobson A., Hylek E., et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 204S-233S
2. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 (2001) 2370-2375
3. Bosson J.L., Labarere J., Sevestre M.A., Belmin J., Beyssier L., Elias A., et al. Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: a multicenter cross-sectional study of risk factors, prophylaxis, and prevalence. Arch Intern Med 163 (2003) 2613-2618
4. van Walraven C., Jennings A., Oake N., Fergusson D., and Forster A.J. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest 129 (2006) 1155-1166
5. Palareti G., Hirsh J., Legnani C., Manotti C., D'Angelo A., Pengo V., et al. Oral anticoagulation treatment in the elderly: a nested prospective case-control study. Arch Intern Med 160 (2000) 470-478
6. Garcia D., Regan S., Crowther M., Hughes R.A., and Hylek E.M. Warfarin Maintenance Dosing Patterns in Clinical Practice: Implications for Safer Anticoagulation in the Elderly Population. Chest 127 (2005) 2049-2056
7. Torn M., Bollen W.L., van der Meer F.J., van der Wall E.E., and Rosendaal F.R. Risks of oral anticoagulant therapy with increasing age. Arch Intern Med 165 (2005) 1527-1532
8. Despotovic N., Erceg P., Nikolic-Despotovic M., Milosevic D.P., and Davidovic M. Bleeding during enoxaparin treatment more common with age over 75 years and severe renal insufficiency. Drugs Aging 24 (2007) 777-779
9. van Walraven C., Oake N., Wells P.S., and Forster A.J. Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromboembolic events in the elderly. Chest 131 (2007) 1508-1515
10. Hylek E.M., Evans-Molina C., Shea C., Henault L.E., and Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115 (2007) 2689-2696
11. Ansell J., Hollowell J., Pengo V., Martinez-Brotons F., Caro J., and Drouet L. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM). J Thromb Thrombolysis 23 (2007) 83-91
12. Kagansky N., Knobler H., Rimon E., Ozer Z., and Levy S. Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med 164 (2004) 2044-2050
13. Wilson S.J., Wells P.S., Kovacs M.J., Lewis G.M., Martin J., Burton E., et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ 169 (2003) 293-298
14. Froom P., Miron E., and Barak M. Oral anticoagulants in the elderly. Br J Haematol 120 (2003) 526-528
15. Gladman J.R., and Dolan G. Effect of age upon the induction and maintenance of anticoagulation with warfarin. Postgrad Med J 71 (1995) 153-155
16. Garcia D., Regan S., Crowther M., Hughes R.A., and Hylek E.M. Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population. Chest 127 (2005) 2049-2056
17. Hylek E.M., Regan S., Go A.S., Hugues R.A., Singer D.E., and Skates S.J. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med 135 (2001) 393-400
18. Hutten B.A., Prins M.H., Gent M., Ginsberg J., Tijssen J.G., and Büller H.R. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 18 (2000) 3078-3083
19. Penning-van Beest F.J., van Meegen E., Rosendaal F.R., and Stricker B.H. Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation. Thromb Haemost 86 (2001) 569-574
20. Ansell J., Hirsh J., Poller L., Bussey H., Jacobson A., and Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 204S-233S
21. Siguret V., Gouin I., Debray M., Perret-Guillaume C., Boddaert J., Mahe I., et al. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen. Am J Med 118 (2005) 137-142
22. Heneghan C., Alonso-Coello P., Garcia-Alamino J.M., Perera R., Meats E., and Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 367 (2006) 404-411
23. Turpie A.G. New oral anticoagulants in atrial fibrillation. Eur Heart J 29 (2008) 155-165